Clinical Trials
8
Active:0
Completed:1
Trial Phases
2 Phases
Early Phase 1:2
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (60.0%)Early Phase 1
2 (40.0%)Mobile Phone Thermal Imaging Assessment of Incompetent Perforator Veins
Not Applicable
Not yet recruiting
- Conditions
- Chronic Venous Disease
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Guangdong Second Provincial General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06834555
To Assess the Effectiveness and Safety of Catheter-based Focal Intracranial Hypothermia Combined with Endovascular Reperfusion Therapy for Patients with Acute Anterior Circulation Large Artery Occlusion
Not Applicable
Recruiting
- Conditions
- Acute Cerebrovascular AccidentAcute Ischemic StrokeInternal Carotid ArteryMiddle Cerebral Artery Occlusion
- Interventions
- Procedure: Mechanical thrombectomyDrug: 4°C saline infusionDrug: Normothermic saline infusion
- First Posted Date
- 2025-01-06
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Guangdong Second Provincial General Hospital
- Target Recruit Count
- 262
- Registration Number
- NCT06758609
- Locations
- 🇨🇳
Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China
To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma
Early Phase 1
Not yet recruiting
- Conditions
- Relapsed or Refractory Multiple Myeloma
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Guangdong Second Provincial General Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06298266
- Locations
- 🇨🇳
Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China
Lung Ultrasound-guided Fluid Resuscitation in Neonatal Septic Shock
Not Applicable
Completed
- Conditions
- Septic Shock
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Guangdong Second Provincial General Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT06144463
- Locations
- 🇨🇳
Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China
JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
Early Phase 1
Recruiting
- Conditions
- Relapsed or Refractory B-cell Lymphoma
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Guangdong Second Provincial General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06045585
- Locations
- 🇨🇳
Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China
- Prev
- 1
- 2
- Next
News
No news found